All filters
Slidesets
Clinical Case Presentation - Max Igor Lopes, MD
Presented at:
São Paulo HIV Clinical Forum 2022
Slidesets
PrEP – State of the ART - Gustavo Lopardo, MD
Presented at:
São Paulo HIV Clinical Forum 2022
Slidesets
HIV and the Liver - Mario Peribañez-Gonzalez, MD, PhD
Presented at:
São Paulo HIV Clinical Forum 2022
Slidesets
Systemic Mycosis in People Living with HIV - José E. Vidal, MD, PhD
Presented at:
São Paulo HIV Clinical Forum 2022
Slidesets
ART in Children and Adolescents - Renata Arrington-Sanders, MD, MPH, ScM
Presented at:
São Paulo HIV Clinical Forum 2022
Slidesets
ART Simplification Strategy - Pedro Cahn, MD, PhD
Presented at:
São Paulo HIV Clinical Forum 2022
Slidesets
ART Update for Patients with Limited Treatment Options - Ricardo Diaz, MD
Presented at:
São Paulo HIV Clinical Forum 2022
Slidesets
Sasisopin Kiertiburanakul - Resistance Considerations in Choice of Regimen
Presented at:
Asia-Pacific HIV Clinical Forum 2022
Slidesets
Implementing LA-ARVs in Europe: Which Patient? Which Formulation?
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Implementing LA-ARVs in Europe: Which Patient? Which Formulation?
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
HIV Transmission Clusters in Europe: A Perspective View of Late Presenters and Non-Late Presenters
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Transmitted Drug Resistance to Integrase Based First-Line Treatment in Europe, 2018-2021
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
New Antiretroviral Compounds: What Are the Resistance Concerns?
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
New Antiretroviral Compounds: What Are the Resistance Concerns?
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
The Top 10 Important Observations Last Year
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Country Experiences: Southern Europe / Italy
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Country Experiences: Northern Europe / Sweden
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Country Experiences: Eastern Europe / Czech Republic
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Country Experiences: Western Europe / France
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Levels and Durability of Humoral and T-Specific Responses After the Booster Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Impact of Sars-Cov-2 Omicron and Delta Sub-Lineage AY.4.2 Variant on Neutralization by Sera of Patients Treated With Different Licensed Monoclonal Antibodies
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Circulation of SARS-CoV-2 Variants in Central Italy: Spike Variability Characterization by Deep-Sequencing (#2)
Presented at:
European Meeting on HIV & Hepatitis 2022